Medis has acquired 1 company. A total of 1 acquisition came from private equity firms.
The Company’s most targeted sectors include life science (100%).
| Date | Target |
Value
$mlns |
Transaction Type | Acquirer | Seller |
SRC
Link |
|---|---|---|---|---|---|---|
| 2008-04-24 |
Inpha-Medis SpA · Life Science
el-Tarf, Algeria · www.inphamedis-dz.com Inpha-Medis is an Algerian pharmaceutical company specialized in the manufacture and marketing of generic drugs. Inpha-Medis produces syrups, antibiotic and non antibiotic tablets and packages sterile forms. The Inpha-Medis plant, which is located in Annaba, 100 Km away from the Tunisian border, started operations in 2005. Currently, the laboratory has two production lines, one for syrup and one for dry forms. The company is expanding its product range thanks to the partnership with Medis, a Tunisian leader in the manufacture of dry and sterile medicines. |
- | Add-on Acquisition |
Africinvest
PE
|
- |
Unlimited Searches Unlimited Profile Views Build and Export Lists of
Mergr is a user-friendly database designed to simplify the complex world of private equity and M&A for busy professionals.
We created Mergr to eliminate the challenge of tracking company acquisitions, sales, and ownership, providing clear insights into investment firms and their activities. For example, explore an investment firm’s investment criteria, deal history, portfolio, and connections - organized to help you uncover opportunities and make informed decisions.
With Mergr, gain access to a comprehensive, interconnected web of transactions, investors, companies, and advisors - all in one place.
Full access to Mergr's investor, acquirer, and transaction data starts here.
